These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7033074)

  • 21. [High doses of cytosine arabinoside in the treatment of refractory leukemia].
    Klener P; Háber J; Kolesková E
    Sb Lek; 1987 Sep; 89(8-9):271-5. PubMed ID: 3478794
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
    Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
    [No Abstract]   [Full Text] [Related]  

  • 24. Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia.
    Greenberg ML; Waxman S
    Eur J Cancer (1965); 1976 Aug; 12(8):617-23. PubMed ID: 1086210
    [No Abstract]   [Full Text] [Related]  

  • 25. Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia.
    Bodey GP; Freireich EJ; McCredie KB; Rodriguez V; Burgess MA; Frei E
    Med Pediatr Oncol; 1975; 1(1):29-35. PubMed ID: 1066520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxicity associated with systemic high-dose cytosine arabinoside.
    Nand S; Messmore HL; Patel R; Fisher SG; Fisher RI
    J Clin Oncol; 1986 Apr; 4(4):571-5. PubMed ID: 3457102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside.
    Balaban EP; Cox JV; Schneider NR; Harth CA; Haley BB; Sheehan R; Frenkel EP
    Am J Hematol; 1988 Oct; 29(2):79-84. PubMed ID: 3189306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
    Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
    Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
    [No Abstract]   [Full Text] [Related]  

  • 33. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.
    Burke PJ; Karp JE; Braine HG; Vaughan WP
    Cancer Res; 1977 Jul; 37(7 Pt 1):2138-46. PubMed ID: 266416
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response.
    Bickers JN; Gehan EA; Freireich EJ; Coltman CA; Wilson HE; Hewlett JS; Stuckey WJ; Van Slyck EJ
    Arch Intern Med; 1974 Feb; 133(2):251-9. PubMed ID: 4521467
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia.
    Roberts JD; Ershler WB; Tindle BH; Stewart JA
    Cancer; 1985 Sep; 56(5):1001-5. PubMed ID: 3860278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of cytosine arabinoside-induced increment in growth fraction of leukemic blast cells with clinical response.
    Vogler WR; Cooper LE; Groth DP
    Cancer; 1974 Mar; 33(3):603-10. PubMed ID: 4544535
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia.
    Sokal JE; Gockerman JP; Bigner SH
    Leuk Res; 1988; 12(6):453-8. PubMed ID: 3165485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
    Amadori S; Petti MC; Mastrovincenzo C; Testa MG
    Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.